Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2012 | 1 |
2015 | 1 |
2016 | 1 |
2018 | 1 |
2019 | 1 |
2020 | 1 |
2023 | 1 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Idelalisib (PI3Kδ inhibitor) therapy for patients with relapsed/refractory chronic lymphocytic leukemia: A Swedish nation-wide real-world report on consecutively identified patients.
Eur J Haematol. 2023 Nov;111(5):715-721. doi: 10.1111/ejh.14065. Epub 2023 Jul 27.
Eur J Haematol. 2023.
PMID: 37501508
Free article.
Risk-adapted bendamustine + rituximab is a tolerable treatment alternative for elderly patients with chronic lymphocytic leukaemia: a regional real-world report on 141 consecutive Swedish patients.
Mattsson A, Sylvan SE, Asklid A, Wiggh J, Winqvist M, Lundin J, Mansouri L, Rosenquist R, Johansson H, Österborg A, Hansson L.
Mattsson A, et al. Among authors: sylvan se.
Br J Haematol. 2020 Nov;191(3):426-432. doi: 10.1111/bjh.17032. Epub 2020 Aug 10.
Br J Haematol. 2020.
PMID: 32779190
Free PMC article.
Item in Clipboard
Sensitivity of chronic lymphocytic leukemia cells to small targeted therapeutic molecules: An in vitro comparative study.
Sylvan SE, Skribek H, Norin S, Muhari O, Österborg A, Szekely L.
Sylvan SE, et al.
Exp Hematol. 2016 Jan;44(1):38-49.e1. doi: 10.1016/j.exphem.2015.08.009. Epub 2015 Aug 29.
Exp Hematol. 2016.
PMID: 26325331
Free article.
Item in Clipboard
Trends in incidence, prevalence, and survival of breast cancer in the United Kingdom from 2000 to 2021.
Barclay NL, Burn E, Delmestri A, Duarte-Salles T, Golozar A, Man WY, Tan EH, Tietzova I; OPTIMA Consortium; Prieto-Alhambra D, Newby D.
Barclay NL, et al.
Sci Rep. 2024 Aug 17;14(1):19069. doi: 10.1038/s41598-024-69006-1.
Sci Rep. 2024.
PMID: 39153995
Free PMC article.
Item in Clipboard
First-line therapy in chronic lymphocytic leukemia: a Swedish nation-wide real-world study on 1053 consecutive patients treated between 2007 and 2013.
Sylvan SE, Asklid A, Johansson H, Klintman J, Bjellvi J, Tolvgård S, Kimby E, Norin S, Andersson PO, Karlsson C, Karlsson K, Lauri B, Mattsson M, Sandstedt AB, Strandberg M, Österborg A, Hansson L.
Sylvan SE, et al.
Haematologica. 2019 Apr;104(4):797-804. doi: 10.3324/haematol.2018.200204. Epub 2018 Nov 22.
Haematologica. 2019.
PMID: 30467205
Free PMC article.
Clinical Trial.
Item in Clipboard
Phase I study of lenalidomide and alemtuzumab in refractory chronic lymphocytic leukaemia: maintaining immune functions during therapy-induced immunosuppression.
Sylvan SE, Rossmann E, Mozaffari F, Porwit A, Norin S, Karlsson C, Hansson L, Lundin J, Österborg A.
Sylvan SE, et al.
Br J Haematol. 2012 Dec;159(5):608-12. doi: 10.1111/bjh.12077. Epub 2012 Oct 9.
Br J Haematol. 2012.
PMID: 23043283
Free article.
Clinical Trial.
No abstract available.
Item in Clipboard
Cite
Cite